CP-199 Effectiveness and safety of eculizumab in atypical haemolytic uraemic syndrome and thrombotic microangiopathy

S Gómez-Álvarez; P Llopis-Salvia; A Avila-Bernabeu; L Pallardó-Mateu; M Climente-Martí

doi:10.1136/ejhpharm-2016-000875.199

Article info

Clinical pharmacy

CP-199 Effectiveness and safety of eculizumab in atypical haemolytic uraemic syndrome and thrombotic microangiopathy

Authors

S Gómez-Álvarez 1Universitary Hospital Doctor Peset, Pharmacy, Valencia, Spain PubMed articles Google scholar articles
P Llopis-Salvia 1Universitary Hospital Doctor Peset, Pharmacy, Valencia, Spain PubMed articles Google scholar articles
A Avila-Bernabeu 2Universitary Hospital Doctor Peset, Nephrology, Valencia, Spain PubMed articles Google scholar articles
L Pallardó-Mateu 2Universitary Hospital Doctor Peset, Nephrology, Valencia, Spain PubMed articles Google scholar articles
M Climente-Martí 1Universitary Hospital Doctor Peset, Pharmacy, Valencia, Spain PubMed articles Google scholar articles

Citation

Gómez-Álvarez S, Llopis-Salvia P, Avila-Bernabeu A, et al

CP-199 Effectiveness and safety of eculizumab in atypical haemolytic uraemic syndrome and thrombotic microangiopathy

European Journal of Hospital Pharmacy 2016;23:A88.

Publication history

First published February 14, 2016.

Online issue publication

May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password